Skip to content

Insider · CIK 0001355415

William D Clark

director

Files at ALDX (Aldeyra Therapeutics, Inc.), IBIO (iBio, Inc.). First filing Jan 13, 2025, latest Jan 13, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$4,999 bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

IBIO: iBio, Inc.

IBIOOct 9, 2026 · close 0.87

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
38Weak
IBIObuy 5
iBio, Inc.
$4,999
1,838 shares
--

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 20, 2025IBIO
iBio, Inc.
AGrant or award
Stock Option (right to buy)derivative
+13,500$0.00$013,500Nov 24, 2025
Apr 17, 2025ALDX
Aldeyra Therapeutics, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+76,760$0.00$076,760Apr 18, 2025
Jan 10, 2025IBIO
iBio, Inc.
POpen-market purchase
Common Stock
+1,838$2.72$4,9991,838Jan 13, 2025
Nov 21, 2024IBIO
iBio, Inc.
AGrant or award
Stock Option (right to buy)derivative
+18,900$0.00$018,900Nov 25, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

William D Clark: insider trades and track record | InsiderTell